Brief: UCB Announces New Biologics Manufacturing Facility In U.S.
12/06/2025 17:45
June 12 (Reuters) - Ucb SA UCB.BR: ANNOUNCES NEW BIOLOGICS MANUFACTURING FACILITY IN U.S. PROJECT TO DELIVER $5 BILLION ECONOMIC IMPACT NEW FACILITY TO CREATE 300 PERMANENT JOBS AND 500 CONSTRUCTION JOBS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on UCB SA
See all newsAnalysis: US prices for new drugs fell in 2025 as fewer costly gene therapies were launched
Brief: UCB Announces Data Showing Positive Impact Of Kygevvi In Tk2d Patients
Brief: UCB Completes $2.2 Billion Acquisition Of Candid Therapeutics
Europe Research Roundup: Banca Generali, Ferrari, Prysmian
Barclays downgrades UCB after rally, sees limited upside